A Statement from Thomas F. Anders, M.D., President of the American Academy of Child and Adolescent Psychiatry
Washington, D.C., February 6, 2007 – The American Academy of Child and Adolescent Psychiatry (AACAP), along with other professional organizations, academic institutions, professional journals and the pharmaceutical industry, all are working toward protecting the integrity of clinical research and ensuring that accurate and complete data are disseminated following each clinical study. The commitment made by the pharmaceutical industry to register all clinical trials in public databases, like ClinicalTrials.gov, and to publish accurate results of these trials is necessary.
The commitment to registration is critical to protecting the child and adolescent subjects in these trials, as well as all children who are treated subsequent to the trials. Child and adolescent psychiatrists, like all physicians, need access to all relevant data in order to make optimal treatment decisions for their patients.
The AACAP supports these and other actions designed to enhance the transparency of clinical research.
###
The American Academy of Child and Adolescent Psychiatry's (AACAP) mission is to actively promote mentally healthy children, adolescents and families through research, training, advocacy, prevention, comprehensive diagnosis and treatment, peer support, and collaboration. Representing over 7,500 child and adolescent psychiatrists, the American Academy of Child and Adolescent Psychiatry is the leading authority on children’s mental health. To learn more about the AACAP, please visit www.aacap.org.
Washington, D.C., February 6, 2007 – The American Academy of Child and Adolescent Psychiatry (AACAP), along with other professional organizations, academic institutions, professional journals and the pharmaceutical industry, all are working toward protecting the integrity of clinical research and ensuring that accurate and complete data are disseminated following each clinical study. The commitment made by the pharmaceutical industry to register all clinical trials in public databases, like ClinicalTrials.gov, and to publish accurate results of these trials is necessary.
The commitment to registration is critical to protecting the child and adolescent subjects in these trials, as well as all children who are treated subsequent to the trials. Child and adolescent psychiatrists, like all physicians, need access to all relevant data in order to make optimal treatment decisions for their patients.
The AACAP supports these and other actions designed to enhance the transparency of clinical research.
###
The American Academy of Child and Adolescent Psychiatry's (AACAP) mission is to actively promote mentally healthy children, adolescents and families through research, training, advocacy, prevention, comprehensive diagnosis and treatment, peer support, and collaboration. Representing over 7,500 child and adolescent psychiatrists, the American Academy of Child and Adolescent Psychiatry is the leading authority on children’s mental health. To learn more about the AACAP, please visit www.aacap.org.
